Intervacc

Intervacc P/E

The (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. of Intervacc (IVACC.ST) as of Nov 6, 2026 is -3.63. In the previous year, (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. was -3.88 — a change of -6.56% (higher).

P/E

-3.63

YoY

-6.56%

Last updated:

As of Nov 6, 2026, Intervacc's P/E ratio was -3.63, a -6.56% change from the -3.88 P/E ratio recorded in the previous year.

The Intervacc P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/E
Date
P/E
Jan 1, 2019
-10.51 SEK
Jan 1, 2020
-11.45 SEK
Jan 1, 2021
-9.98 SEK
Jan 1, 2022
-4.57 SEK
Jan 1, 2023
-2.85 SEK
Jan 1, 2024
-3.88 SEK
Jan 1, 2025
-3.63 SEK
Jan 1, 2026 (e)
-4.09 SEK
The Intervacc P/E history
YEARP/EYoY
est-4.09+12.77%
-3.63-6.56%
-3.88+36.20%
-2.85-37.62%
-4.57-54.21%
-9.98-12.85%
-11.45+8.95%
-10.51-1.43%
-10.66-53.56%
-22.96-46.68%
-43.06-102.03%
2,122.72+6,652.51%
31.44—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intervacc Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Intervacc's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Intervacc's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Intervacc's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Intervacc grows earnings faster than its peers.

Intervacc Stock analysis

What does Intervacc do? Intervacc AB is a Swedish biotechnology company specializing in the development and production of vaccines for animals. The company was founded in 2003 by researchers who wanted to develop an alternative to traditional vaccines made from weakened or killed pathogens. Intervacc AB's business model is based on the development of subunit vaccines, which consist of the key proteins of the pathogens and allow targeted immune responses in animals. Subunit vaccines are safe and effective, offering many advantages over traditional vaccines by minimizing the risk of side effects and allowing targeted combat against specific pathogens. The different divisions at Intervacc AB include the development of vaccines for animals such as horses, pigs, chickens, and cattle. The company also has plans to develop vaccines for other animal species in the future, such as dogs and cats. Among the products offered by Intervacc AB are various vaccines in different stages of development. One of its key products is Equilis StrepE, used for the preventive treatment of myopathy in horses. The vaccination is already being used in many countries and is an important part of horse healthcare. Another product is Porcilis AR-T DF, used to vaccinate pigs against atrophic rhinitis (AR). Intervacc AB is also developing new products, such as a vaccine for the prevention of Lyme borreliosis in horses and a vaccine against bacterial pneumonia in calves. The company is constantly searching for new vaccines to improve animal health and welfare, and several patents have been filed. The history of Intervacc AB is marked by ambitious goals and scientific breakthroughs. In 2004, the first steps were taken towards developing subunit vaccines for horse diseases. In 2007, the company began clinical trials of Equilis StrepE, which was later acquired by Boehringer Ingelheim Animal Health in 2016. In 2011, Intervacc AB developed Porcilis AR-T DF, a vaccine against atrophic rhinitis in pigs. Since then, the company has expanded its research and development into various areas and formed numerous partnerships. Intervacc AB utilizes cutting-edge technologies and has an experienced team of scientists and professionals who collaborate closely to develop and test new vaccines. The company is based in Uppsala, Sweden, and has state-of-the-art laboratory and production facilities. Overall, Intervacc AB has established itself as an innovative company specializing in the development of safe and effective vaccines for animals. Its products and services contribute to improving the health and well-being of animals and making animal husbandry more sustainable and efficient. Intervacc is one of the most popular companies on Eulerpool.

P/E Details

Deciphering Intervacc's P/E Ratio

The Price to Earnings (P/E) Ratio of Intervacc is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Intervacc's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Intervacc is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Intervacc’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Intervacc stock

(Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. of Intervacc is -3.63 in 2025.

(Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. of Intervacc changed from -3.88 to -3.63, representing a -6.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account. Intervacc since 2006 – with annual values, charts, and detailed analysis.

The price-earnings ratio (P/E ratio) is a key figure for evaluating a stock. The stock price is compared to the earnings per share. The ratio therefore expresses the number of years it takes for a company to generate the current earnings to match the stock price.

P/E ratio formula:
P/E ratio = Stock price / Earnings per Share (EPS)
If the earnings per share (EPS) is not readily available, it can be calculated by dividing the company's total earnings by the number of shares issued.

EPS formula:
Total earnings of the company / Number of shares issued
The earnings per share (EPS) can usually be easily found on most financial websites.

The P/E ratio is one of the most commonly used indicators for valuing stocks. However, the correct application of the P/E ratio is slightly more complicated than the formula described above would suggest. Therefore, it is always only a snapshot and not a reliable consideration of the future. If future earnings were to increase without any change in the stock price, the P/E ratio would accordingly decrease.

To evaluate (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account.'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account..

A 'good' varies by industry and company stage. On Eulerpool, you can compare (Price Earnings Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the earnings per share. The P/E indicates how many years it would take to recoup the current share price through the expected earnings per share. A low P/E may indicate that a stock is undervalued, while a high P/E may suggest an overvalued stock. However, the P/E alone should not be considered the sole basis for an investment decision, as other factors must also be taken into account.'s Intervacc with sector peers and the industry average to assess whether it is attractive.

The P/E ratio in evaluating a stock.

The price-earnings ratio (P/E ratio) is an important financial ratio that is often used by investors to assess the attractiveness of a stock. It is an indicator of a company's earnings and valuation, and provides an indication of whether a stock is overvalued or undervalued. It is also used as an indicator of whether a stock is "expensive" or "cheap".

History of P/E ratio

The P/E ratio was first used in 1881 by the famous financial scientist Benjamin Graham. He developed the P/E ratio as a means to evaluate whether a stock is trading at a "good" or "bad" price. Since then, the P/E ratio has had a long history in the financial world, particularly among investors who are looking for a way to evaluate stocks in an informed manner.

Calculation of the P/E ratio

The P/E ratio is calculated by dividing the current stock price by the earnings per share. A simple formula for calculating the P/E ratio is as follows:

P/E ratio = Stock price / Earnings per share

Example: If a stock is traded at the current price of $10 and the earnings per share is $1, the P/E ratio would be 10 ($10 / $1 = 10).

Application of the P/E ratio

Investors use the P/E ratio to assess the attractiveness of a stock. A high P/E ratio can indicate that a stock is overvalued, while a low P/E ratio means that a stock is undervalued. Investors can then decide whether to buy, sell, or hold a stock based on this information. Another reason why investors use the P/E ratio is to check how stocks perform compared to other stocks or the market as a whole. If a stock's P/E ratio is higher than the overall market's P/E ratio, this may mean that the stock is overvalued, and investors can decide whether to sell or hold the stock. Investors usually also use the P/E ratio to compare stocks over time. If a stock has a P/E ratio of 10 and a year later has a P/E ratio of 20, this may mean that the stock is overvalued. Investors can then decide whether to hold or sell the stock.

Advantages and Disadvantages of using the P/E ratio

BenefitsThe P/E ratio is a useful tool to assess the attractiveness of a stock and to evaluate how a stock is performing compared to the market. It is a simple tool that can assist investors in deciding whether to buy, sell, or hold a stock.

DisadvantagesThe P/E ratio is a simple tool that does not provide any information about the future performance of a stock. It can be difficult to predict the future performance of a stock, and sometimes the P/E ratio can give a false picture of a stock. Therefore, investors must be cautious when relying on the P/E ratio.

In addition, the P/E ratio can vary depending on the industry, which makes comparability difficult. For example, a stock in a certain industry may have a low P/E ratio, while another stock in a different industry may have a higher P/E ratio. Therefore, investors must be cautious when relying on the P/E ratio.

Conclusion

The P/E ratio is a useful tool that can assist investors in assessing the attractiveness and value of a stock. It can also be used to check how a stock is performing in comparison to the market. However, it is important to note that it is a simple tool that does not make any statement about the future performance of a stock, and investors must be cautious when relying on the P/E ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Intervacc

All Key Metrics — Intervacc